Trials / Unknown
UnknownNCT04174586
Cord Blood Microtransplantation for Treatment of Acute Myeloid Leukemia
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- The Affiliated Hospital of the Chinese Academy of Military Medical Sciences · Academic / Other
- Sex
- All
- Age
- 60 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Discuss the effectiveness and safety of cord blood microtransplantation for treatment of acute myeloid leukemia
Detailed description
The investigators conducted a prospective, single center clinical trial to dissuss the outcomes and toxicities of HLA-mismatched cord blood infusion after chemotherapy (microtransplantation) in older patients with acute myeloid leukemia (AML)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | microtransplantation | HLA mismatched donor cord blood infusion |
Timeline
- Start date
- 2020-01-22
- Primary completion
- 2024-08-31
- Completion
- 2024-08-31
- First posted
- 2019-11-22
- Last updated
- 2020-03-26
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04174586. Inclusion in this directory is not an endorsement.